The DOI matches its Crossref record.
A Decade of Controversy: Balancing Policy With Evidence in the Regulation of Prescription Drug Advertising
Open accessAbstract
Direct-to-consumer advertising (DTCA) of prescription drugs has remained controversial since regulations were liberalized by the Food and Drug Administration in 1997. We reviewed empirical evidence addressing the claims made in the policy debate for and against DTCA. This advertising has some benefits, but significant risks are evident as well, magnified by the prominence of DTCA in population-level health communications. To minimize potential harm and maximize the benefits of DTCA for population health, the quality and quantity of information should be improved to enable consumers to better self-identify whether treatment is indicated, more realistically appraise the benefits, and better attend to the risks associated with prescription drugs. We propose guidelines for improving the utility of prescription drug advertising.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Medical Marketing in the United States, 1997-2016
Schwartz, L. M., & Woloshin, S. (2019) · JAMA · doi:10.1001/jama.2018.19320 · Cited by 379
The Continued Social Transformation of the Medical Profession
Timmermans, S., & Oh, H. (2010) · Journal of Health and Social Behavior · doi:10.1177/0022146510383500 · Cited by 304
The Role of Informatics in Promoting Patient-Centered Care
Snyder, C. F., Wu, A. W., Miller, R. S., Jensen, R. E., Bantug, E. T., & Wolff, A. C. (2011) · The Cancer Journal · doi:10.1097/ppo.0b013e318225ff89 · Cited by 166
Park, J. S., & Ju, I. (2016) · Health Communication · doi:10.1080/10410236.2014.957375 · Cited by 29
Metadata
- Authors
- Frosch, D. L., Grande, D., Tarn, D. M., & Kravitz, R. L.
- Venue
- American Journal of Public Health
- Publisher
- American Public Health Association
- Published
- 2010-01
- Volume
- 100
- Issue
- 1
- Pages
- 24-32
- ISSN
- 0090-0036 (ISSN-L)
- 1541-0048
- OpenAlex
- W2131401904
- Cited by
- 162
- References
- 0
- FWCI
- 11.05
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Decade of Controversy: Balancing Policy With Evidence in the Regulation of Prescription Drug Advertising. https://app.cochat.ai/papers/10.2105/ajph.2008.153767
- The paper
- Frosch, D. L., Grande, D., Tarn, D. M., & Kravitz, R. L. (2010). A Decade of Controversy: Balancing Policy With Evidence in the Regulation of Prescription Drug Advertising. American Journal of Public Health. https://doi.org/10.2105/ajph.2008.153767
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.